EDN1 and cancer: CYP24A1 gene was believed to reduce the efficacy of certain anti-proliferative agents such as vitamin D and its analogues 29, and the EDN1 gene that was known to act as a neoangiogenic and mitogenic factor in several cancers 30 are the best target of cancer therapy study.